
The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA. T., Ikeda, S., Baumgartner, J., Heestand, G. The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.European Journal of Cancer (Oxford, England : 1990), 83, 80–87. Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients. M., Schwaederle, M., Gatalica, Z., Arguello, D., & Kurzrock, R. Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients.Journal of Translational Medicine, 14(1), 339. FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors. FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.Molecular landscape of pancreatic cancer: implications for current clinical trials. Molecular landscape of pancreatic cancer: implications for current clinical trials.JOURNAL OF CLINICAL ONCOLOGY, 33(16), 1770-? Approach to Patients With Pancreatic Cancer Without Detectable Metastases. Approach to Patients With Pancreatic Cancer Without Detectable Metastases.A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. B., Pai, J., Chiu, W., Ng, K., Hellendag, M. A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 105(23), 1814–20.


Racial Disparity in Consultation, Treatment, and the Impact on Survival in Metastatic Colorectal Cancer. E., Gupta, S., Hattangadi-Gluth, J., Mell, L. Racial Disparity in Consultation, Treatment, and the Impact on Survival in Metastatic Colorectal Cancer.
